Loading clinical trials...
Loading clinical trials...
Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo: A Phase 2A Randomized, Double-Blind, Vehicle-Controlled Clinical Trial
Conditions
Interventions
Crisaborole 2 % Topical Ointment
PF-07038124 0.01% topical ointment
+3 more
Locations
1
United States
University of Colorado Anschutz - Clinical and Translational Research Centers
Aurora, Colorado, United States
Start Date
September 7, 2022
Primary Completion Date
April 30, 2024
Completion Date
April 30, 2024
Last Updated
June 12, 2024
NCT07431177
NCT07352293
NCT07437560
NCT07398807
NCT07357870
NCT07267273
Lead Sponsor
University of Colorado, Denver
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions